At a glance · for buyers and watchdogs
NOVARTIS PHARMACEUTICALS UK LIMITED has won £1.7bn across 14 public-sector buyers, with 66 live contracts. No active Companies House risk flags.
Why: top buyer NHS England at 54% · 0 active risk flags · 0 modifications.
ESG & policies vault · 0/5
Key governance & sustainability policies. Published documents link out; missing ones are greyed.
Capabilities
What this supplier does, where they sit, who they sell to.
- NHS England Framework Agreement: South of England (Tranche B)
- NHS England - Midlands and East Branded Medicines - Tranche B
- NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity
- NHS Framework agreement for Branded Medicines - North of England - Tranche A
- NHS Framework for the NHS London Region, Branded Medicines - Tranche A
- NHS Framework Agreement - North of England - Tranche B
Extracted automatically from novartis.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.
Case studies
Delivery stories the supplier has published, with sector and outcome.
No case studies yet
Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.
Buyer references
Named public-sector contacts who have agreed to act as a reference.
No buyer references yet
Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.
Accreditations & memberships
Independently issued. Verification dates cross-checked against issuer registers.
No accreditations recorded
B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.
KPI performance
Delivery, budget and satisfaction scores reported quarterly by buyers.
No verified KPI scores yet
Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.
Contracts · 66 live · 48 historic
Pulled from Contracts Finder & Find a Tender. Most recent first.
| Title | Buyer | CPV | Awarded | Value | Term | Status |
|---|---|---|---|---|---|---|
| BELFAST HEALTH AND SOCIAL CARE TRUST | — | 06 Jul 2026 | £1.0m | 2 yrs | Live | |
| NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | — | 01 Jul 2026 | £16.8m | 2 yrs | pending | |
| BELFAST HEALTH AND SOCIAL CARE TRUST | — | 15 May 2026 | £270k | 1.9 yrs | pending | |
| NHS England | — | 01 Jun 2026 | £529.1m | 1.9 yrs | pending | |
| The Royal Marsden NHS Foundation Trust | — | 19 Dec 2025 | £317k | 10 mo | pending | |
| NHS England | — | 01 Feb 2026 | £87.4m | 1.6 yrs | pending | |
| NHS England | — | 01 Feb 2026 | £21.6m | 1.7 yrs | pending | |
| BELFAST HEALTH AND SOCIAL CARE TRUST | — | 20 Nov 2025 | £1.8m | 13 mo | pending | |
| Western Health and Social Care Trust | — | 01 Dec 2025 | £4.6m | 3 yrs | pending | |
| NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | — | 01 Oct 2025 | £138k | 16 mo | pending |
Top buyers · 14 buyers · top 3 = 99%
Share of awarded value. Concentration fires above 40% for any single buyer.
Geography
Distribution of awarded value by buyer region.
Peers
Suppliers with overlapping CPVs & buyers (last 24m). NOVARTIS PHARMACEUTICALS UK LIMITED highlighted.
| Supplier | SME? | Awarded · 24m | Contracts |
|---|---|---|---|
NP NOVARTIS PHARMACEUTICALS UK LIMITED | No | £1.4bn | — |
| No | £82.0m | 2 | |
| No | £18.7m | 1 | |
| Yes | £3.0m | 4 | |
| Yes | £3.0m | 2 | |
| Yes | £3.0m | 1 |
Red flags · 0 active
Automated scan of Companies House status, charges and insolvency records.
Compliance scorecard
Derived from Companies House filings — not a full supplier-assurance check.
Modifications
Variations to awarded contracts logged under Procurement Act 2023 s.74.
No modifications recorded
No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.
News mentions
UK trade press & nationals, matched to this supplier.
No news mentions found
We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.
Companies House
Live sync — registered details, directors, PSC and SIC codes.
Registered details
- Company no.
- 00119006
- Status
- Active
- Type
- Private limited
- Incorporated
- 08 Dec 1911
- Reg. office
- 2nd Floor, The Westworks Building White City Place, 195 Wood Lane, London, W12 7FQ
- SIC codes
- 21100
- Last accounts
- 31 Dec 2024
- Next accounts due
- 30 Sept 2026
Directors & PSC
- CULLEN, Richard Samuel — secretaryAppointed 01 Jan 2026
- GUPTA, Sandeep — directorAppointed 12 May 2025
- KAHLSTROEM, Johan Mikael Olof — directorAppointed 01 Nov 2024
- Novartis Uk Limited — person with significant controlownership of shares 75 to 100 percent · voting rights 75 to 100 percent · right to appoint and remove directors
Financial
Filed accounts from Companies House.
No financial filings on record
Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.
Org tree
Group structure and ownership.
Independent. No parent company or subsidiaries recorded at Companies House for this entity.
Social value
Commitments mapped to the Government Social Value Model themes.
No social-value commitments yet
Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.